Naloxone Cloridrato Bambini Galenica Senese (Naloxone Hydrochloride Dihydrate)

Naloxone works by competitively binding to μ‑opioid receptors with higher affinity than most opioid agonists. This displaces the opioid molecules from the receptors, halting their depressant actions on the central nervous system and allowing normal breathing and consciousness to return.

The exact dose of naloxone is determined by the prescribing clinician based on the patient’s condition, age, weight, and severity of opioid exposure. Dosing guidelines are provided in clinical protocols, but the prescriber sets the final regimen.

Safety data for naloxone in pregnancy and lactation are limited, and the product is classified as pregnancy category unknown. Clinicians weigh potential benefits against risks, and use is generally reserved for situations where the benefit of reversing opioid toxicity outweighs any theoretical risk.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Naloxone is the most widely used opioid antagonist due to its rapid onset, short duration of action, and well‑established safety profile. Compared with alternatives such as nalmefene, naloxone has a quicker peak effect, making it preferred for emergency reversal, while other agents may be used for longer‑term management of opioid dependence.

Store the injectable solution at ambient temperature, below 25 °C, in its original packaging. Protect it from moisture, direct sunlight, and extreme temperatures. Do not freeze the product, and keep the vial tightly sealed until use.

Naloxone is administered by intramuscular, intravenous, or subcutaneous injection. The route is chosen based on the clinical situation and available access. In emergency settings, intramuscular injection is often preferred for rapid delivery when intravenous access is not immediately available.

The most serious risks include precipitating acute opioid withdrawal, which can cause severe agitation, hypertension, tachycardia, and in rare cases, seizures or cardiac arrhythmias. Anaphylactic reactions are also possible, though uncommon, and require immediate medical attention.

Naloxone is contraindicated in individuals with a known hypersensitivity to naloxone or any of its excipients. It should also be used with caution in patients with severe cardiovascular disease, as rapid reversal of opioid effects can lead to abrupt changes in blood pressure and heart rate.